The use of daclizumab for treatment of steroid refractory acute GVHD. A City of Hope experience No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2005 ASCO ...
HONG KONG – It is not surprising that Tokyo-based Kyowa Hakko Kirin Co. Ltd. wants to hold on to Nesp (darbepoetin alfa), an erythropoiesis-stimulating agent used as a treatment for improving renal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback